Status: Not yet recruiting
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
This clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism. The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments targeting neurodegeneration within dopaminergic pathways.
Participants needed: 120
Trial details
Phase: Phase 2Age: 48-70Biological sex: AllType: InterventionalSponsor: Biocells MedicalUpdated: Mar 13, 2026Locations: 1
Eligibility criteria
Not listed